For pharmaceutical companies engaged in research and development, the selection and sourcing of specialized chemical intermediates are critical for the success of new drug discovery and optimization. Ethyl (R)-(-)-4-cyano-3-hydroxybutyrate, identified by CAS number 141942-85-0, is a prime example of such a compound, particularly valued for its role as an atorvastatin intermediate. NINGBO INNO PHARMCHEM CO.,LTD. supports pharmaceutical R&D by providing this essential chiral building block with high purity and reliable specifications.

The journey of drug development often begins with synthesizing key molecular structures, and for Atorvastatin, Ethyl (R)-(-)-4-cyano-3-hydroxybutyrate is a foundational element. Its defined stereochemistry is vital for researchers aiming to understand and refine the drug's efficacy and safety profile. Companies involved in early-stage drug discovery can benefit from sourcing this chemical with an assay of ≥98.0%, ensuring that their experimental results are based on high-quality, well-characterized materials. NINGBO INNO PHARMCHEM CO.,LTD. understands these R&D needs and provides the necessary product integrity.

When procuring chemicals for research, it's important to consider not only the technical specifications but also the supplier's ability to provide ongoing support and consistent quality. For those looking to buy Ethyl (R)-(-)-4-cyano-3-hydroxybutyrate, NINGBO INNO PHARMCHEM CO.,LTD. offers a partnership approach, ensuring that our clients have a reliable source for their research needs. The availability of this specific atorvastatin intermediate facilitates the exploration of new synthetic routes and the development of improved formulations for cholesterol-lowering therapies.

The effective use of Ethyl (R)-(-)-4-cyano-3-hydroxybutyrate in the synthesis of atorvastatin intermediate underscores the importance of precise chemical sourcing in pharmaceutical R&D. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to empowering researchers and developers with the high-quality chemical tools they need to advance healthcare. We encourage all entities involved in pharmaceutical research to consider our offerings for Ethyl (R)-(-)-4-cyano-3-hydroxybutyrate and to contact us for further information or to place an order.